The value of C-reactive protein in symptomatic versus asymptomatic carotid artery stenosis

References

• Rodríguez-Yáňez M, Castillo J. Role of inflammatory markers in brain ischemia. Curr Opin Neurol 2008;21:353–7.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Nam BH, Wilson PW, Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002;22:1662–7.
   PubMed Web of Science ®Google Scholar
• Magyar MT, Szikszai Z, Balla J, Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 2003;34:58–63.
   PubMed Web of Science ®Google Scholar
• Winbeck K, Kukla C, Poppert H, Elevated C-reactive protein is associated with an increased intima to media thickness of the common carotid artery. Cerebrovasc Dis 2002;13:57–63.
   PubMedGoogle Scholar
• Thakore AH, Guo CY, Larson MG, Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007;99:1598–602.
   PubMed Web of Science ®Google Scholar
• Makita S, Nakamura M, Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 2005;36:2138–42.
   PubMed Web of Science ®Google Scholar
• Hashimoto H, Kitagawa K, Hougaku H, C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001;104:63–7.
   PubMed Web of Science ®Google Scholar
• Van Der Meer IM, De Maat MP, Hak AE, C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study. Stroke 2002;33:2750–5.
   PubMedGoogle Scholar
• Debing E, Peeters E, Demanet C, Markers of inflammation in patients with symptomatic and asymptomatic carotid artery stenosis: a case-control study. Vas Endovascular Surg 2008;42:122–7.
   PubMedGoogle Scholar
• Mullenix PS, Steele SR, Martin MJ, C-reactive protein level and traditional vascular risk factors in the prediction of carotid stenosis. Arch Surg 2007;142:1066–71.
   PubMedGoogle Scholar
• Rerkasem K, Shearman CP, Williams JA, C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease. Eur J Vasc Endovasc Surg 2002;23:505–9.
   PubMedGoogle Scholar
• Alvarez Garcia B, Ruiz C, Chacon P, High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 2003;38:1018–24.
   PubMed Web of Science ®Google Scholar
• Schlager O, Exner M, Mlekusch W, C-reactive protein predicts future cardiovascular events in patients with carotid stenosis. Stroke 2007;38:1263–8.
   PubMedGoogle Scholar
• Schilinger M, Exner M, Mlekusch W, Inflammation and carotid artery-risk for atherosclerosis study (ICARAS). Circulation 2005;111:2203–9.
   PubMedGoogle Scholar
• Arthurs ZM, Andersen C, Starnes BW, A prospective evaluation of C-reactive protein in the progression of carotid artery stenosis. J Vasc Surg 2008;47:744–50.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Choe YH, Bang OH; CHAOS-BIOMARKER Collaborators. Are stroke biomarkers seeing brain vessels in patients with ischemic stroke? : a C-reactive protein and homocysteine study. Stroke 2011;42:1464–8.
   PubMed Web of Science ®Google Scholar
• Grant EG, Benson CB, Moneta GL, Carotid artery stenosis: gray-scale and Doppler US diagnosis–Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003;229:340–6.
   PubMed Web of Science ®Google Scholar
• Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001;104:503–16.
   PubMed Web of Science ®Google Scholar
• Libby P, Okamoto Y, Rocha VZ, Inflammation in atherosclerosis: transition from theory to practice. Circ J 2010;74:213–20.
   PubMed Web of Science ®Google Scholar
• Torzewski M, Rist C, Mortensen RF, C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000;20:2094–99.
   PubMed Web of Science ®Google Scholar
• Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007;27:15–26.
   PubMed Web of Science ®Google Scholar
• Verma S, Szmitko PE, Yeh ETH. C-reactive protein: structure affects function. Circulation 2004;109:1914–17.
   PubMed Web of Science ®Google Scholar
• Ben-Yehuda O. High-sensitivity C-reactive protein in every chart? The use of biomarkers in individual patients. J Am Coll Cardiol 2007;49:2139–41.
   PubMedGoogle Scholar
• Iso H, Noda H, Ikeda A, The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan public health center-based study. J Atheroscler Thromb 2012;19:756–66.
   PubMed Web of Science ®Google Scholar
• Molino-Lova R, Macchi C, Gori AM, High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older persons. Nutr Metab Cardiovasc Dis 2011;21:776–82.
   PubMedGoogle Scholar
• Sitzer M, Markus HS, Mendall MA, C-reactive protein and carotid intimal medial thickness in a community population. J Cardiovasc Risk 2002;9:97–103.
   PubMedGoogle Scholar
• Lorenz MW, Karbstein P, Markus HS, High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke 2007;38:1774–9.
   PubMedGoogle Scholar
• Chapman CM, Beilby JP, McQuillan BM, Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004;35:1619–24.
   PubMed Web of Science ®Google Scholar
• Choi HC, Cho DH, Shin HH, Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 2004;68:297–303.
   PubMed Web of Science ®Google Scholar
• Schulze Horn C, Ilg R, Sander K, High-sensitivity C-reactive protein at different stages of atherosclerosis: result of the INVADE study. J Neurol 2009;256:783–91.
   PubMed Web of Science ®Google Scholar
• Faggioli G, Fittipaldi S, Pini R, C-reactive protein and embolization during carotid artery stenting. A serological and morphological study. Histol Histopathol 2011;26:843–53.
   PubMedGoogle Scholar
• Heider P, Pelisek J, Poppert H, Eckstein HH. Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease. Vasc Endovascular Surg 2009;43:551–60.
   PubMedGoogle Scholar
• Giannoukas AD, Sfyroeras GS, Griffin M, Association of plaque echostructure and cardiovascular risk factors with symptomatic carotid artery disease. Vasa 2009;38:357–64.
   PubMedGoogle Scholar
• van Lammeren GW, den Hartog AG, Pasterkamp G, Asymptomatic carotid artery stenosis: identification of subgroups with different underlying plaque characteristics. Eur J Vasc Endovasc Surg 2012;43:632–6.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115–26.
   PubMed Web of Science ®Google Scholar
• Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis 1990;81:33–40.
   PubMed Web of Science ®Google Scholar
• Elkind MS, Cheng J, Boden-Albala B, Elevated white blood cell count and carotid plaque thickness. The Northern Manhattan Stroke Study. Stroke 2001;32:842–9.
   PubMed Web of Science ®Google Scholar
• Huang ZS, Jeng JS, Wang CH, Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis 2001;158:431–6.
   PubMedGoogle Scholar
• Ishizaka N, Ishizaka Y, Toda E, Association between white blood cell count and carotid arteriosclerosis in Japanese smokers. Atherosclerosis 2004;175:95–100.
   PubMedGoogle Scholar
• Temelkova-Kurktschiev T, Koehler C, Henkel E, Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes. Cardiovasc Res 2002;56:277–83.
   PubMedGoogle Scholar
• Schratzberger P, Dunzendorfer S, Reinisch N, Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils. Cardiovasc Res 1998;38:516–21.
   PubMedGoogle Scholar
• Couderc R, Bonneau C, Tissot M, Effects of plasma lipoproteins on the production of superoxide anion by human polymorphonuclear leukocytes in vitro. BioFactors 1997;6:157–63.
   PubMedGoogle Scholar
• Blann AD, Seigneur M, Adams RA, Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis. Eur J Vasc Endovasc Surg 1996;12:218–22.
   PubMedGoogle Scholar
• Boyajian RA, Otis SM. Atherogenic progression of carotid stenosis associates selectively with monocyte fraction in circulating leukocytes. Eur J Neurol 2002;9:307–10.
   PubMedGoogle Scholar
• Nasr N, Ruidavets JB, Arnal JF, Association of neutrophil count with microembolism in patients with symptomatic carotid artery stenosis. Atherosclerosis 2009;207:519–23.
   PubMedGoogle Scholar
• De Silva DA, Woon FP, Gan HY, Arterial stiffness is associated with raised levels of the inflammatory marker erythrocyte sedimentation rate among ischaemic stroke patients. Intern Med 2008;38:918–20.
   Google Scholar
• Assayag EB, Bova I, Kesler A, Erythrocyte aggregation as an early biomarker in patients with asymptomatic carotid stenosis. Dis Markers 2008;24:33–9.
   PubMedGoogle Scholar
• Schönbeck U, Libby P. Inflammation, immunity and HMG-CoA reductase inhibitors: statins as anti-inflammatory agents? Circulation 2004;109:II 18–26.
   PubMedGoogle Scholar
• Solheim S, Arnesen H, Eikvar L, Influence of aspirin on inflammatory markers in patients after acute myocardial infarction. Am J Cardiol 2003;92:843–5.
   PubMedGoogle Scholar